Generation of An Induced Pluripotent Stem Cell Line from Human Liver Fibroblasts from A Patient with Combined Hepatocellular-Cholangiocarcinoma

Objective: Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare type of primary liver cancer with characteristics of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). The pathogenesis of cHCCCC is poorly understood due to a shortage of suitable in vitro models. Due to scar...

Full description

Bibliographic Details
Main Authors: Hyo-Suk Ahn, Jae-Sung Ryu, Jaeseo Lee, Seon Ju Mun, Yeon-Hwa Hong, Yongbo Shin, Kyung-Sook Chung, Myung Jin Son
Format: Article
Language:English
Published: Royan Institute (ACECR), Tehran 2022-03-01
Series:Cell Journal
Subjects:
Online Access:https://celljournal.org/journal/article/fulltext/generation-of-an-induced-pluripotent-stem-cell-line-from-human-liver-fibroblasts-of-a-patient-with-combined-hepatocellular-cholangiocarcinoma.pdf
_version_ 1811271579577876480
author Hyo-Suk Ahn
Jae-Sung Ryu
Jaeseo Lee
Seon Ju Mun
Yeon-Hwa Hong
Yongbo Shin
Kyung-Sook Chung
Myung Jin Son
author_facet Hyo-Suk Ahn
Jae-Sung Ryu
Jaeseo Lee
Seon Ju Mun
Yeon-Hwa Hong
Yongbo Shin
Kyung-Sook Chung
Myung Jin Son
author_sort Hyo-Suk Ahn
collection DOAJ
description Objective: Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare type of primary liver cancer with characteristics of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). The pathogenesis of cHCCCC is poorly understood due to a shortage of suitable in vitro models. Due to scarce availability of human liver tissue, induced pluripotent stem cells (iPSCs) are a useful alternative source to produce renewable liver cells. For use in the development of liver pathology models, here we successfully developed and evaluated iPSCs from liver fibroblasts of a patient with cHCC-CC. Materials and Methods: In this experimental study, human liver fibroblasts (HLFs) were obtained from the liver biopsy of a 69-year-old male patient with cHCC-CC and transduced with a retroviral cocktail that included four factors - OCT4, SOX2, KLF4, and c-MYC (OSKM). Pluripotency of the iPSCs was determined by alkaline phosphatase (AP) staining, quantitative real-time polymerase chain reaction (PCR), and immunofluorescence. We induced in vitro embryoid body (EB) formation and performed an in vivo teratoma assay to confirm their differentiation capacity into the three germ layers. Results: HLF iPSCs derived from the cHCC-CC patient displayed typical iPSC-like morphology and pluripotency marker expression. The proficiency of the iPSCs to differentiate into three germ layers was assessed both in vitro and in vivo. Compared to normal control iPSCs, differentiated HLF iPSCs showed increased expressions of HCC markers alpha-fetoprotein (AFP) and Dickkopf-1 (DKK1) and the CC marker cytokeratin 7 (CK7), and a decreased expression of the CC tumour suppressor SRY-related HMG-box 17 (SOX17). Conclusion: We established HLF iPSCs using liver fibroblasts from a patient with cHCC-CC for the first time. The HLF iPSCs maintained marker expression in the patient when differentiated into EBs. Therefore, HLF iPSCs may be a sustainable cell source for modelling cHCC-CC and beneficial for understanding liver cancer pathology and developing therapies for cHCC-CC treatment.
first_indexed 2024-04-12T22:23:32Z
format Article
id doaj.art-00d53389845544ad870ed67297f606df
institution Directory Open Access Journal
issn 2228-5806
2228-5814
language English
last_indexed 2024-04-12T22:23:32Z
publishDate 2022-03-01
publisher Royan Institute (ACECR), Tehran
record_format Article
series Cell Journal
spelling doaj.art-00d53389845544ad870ed67297f606df2022-12-22T03:14:15ZengRoyan Institute (ACECR), TehranCell Journal2228-58062228-58142022-03-0124313313910.22074/cellj.2022.7765Generation of An Induced Pluripotent Stem Cell Line from Human Liver Fibroblasts from A Patient with Combined Hepatocellular-CholangiocarcinomaHyo-Suk Ahn0Jae-Sung Ryu1Jaeseo Lee2Seon Ju Mun3Yeon-Hwa Hong4Yongbo Shin5Kyung-Sook Chung6Myung Jin Son7Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, Republic of KoreaStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, Republic of KoreaStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, Republic of KoreaStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, Republic of KoreaStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, Republic of KoreaStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, Republic of KoreaDepartment of Functional Genomics, Korea University of Science and Technology (UST), 217 Gajungro, Yuseong-gu, Daejeon, Republic of KoreaDepartment of Functional Genomics, Korea University of Science and Technology (UST), 217 Gajungro, Yuseong-gu, Daejeon, Republic of KoreaObjective: Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare type of primary liver cancer with characteristics of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC). The pathogenesis of cHCCCC is poorly understood due to a shortage of suitable in vitro models. Due to scarce availability of human liver tissue, induced pluripotent stem cells (iPSCs) are a useful alternative source to produce renewable liver cells. For use in the development of liver pathology models, here we successfully developed and evaluated iPSCs from liver fibroblasts of a patient with cHCC-CC. Materials and Methods: In this experimental study, human liver fibroblasts (HLFs) were obtained from the liver biopsy of a 69-year-old male patient with cHCC-CC and transduced with a retroviral cocktail that included four factors - OCT4, SOX2, KLF4, and c-MYC (OSKM). Pluripotency of the iPSCs was determined by alkaline phosphatase (AP) staining, quantitative real-time polymerase chain reaction (PCR), and immunofluorescence. We induced in vitro embryoid body (EB) formation and performed an in vivo teratoma assay to confirm their differentiation capacity into the three germ layers. Results: HLF iPSCs derived from the cHCC-CC patient displayed typical iPSC-like morphology and pluripotency marker expression. The proficiency of the iPSCs to differentiate into three germ layers was assessed both in vitro and in vivo. Compared to normal control iPSCs, differentiated HLF iPSCs showed increased expressions of HCC markers alpha-fetoprotein (AFP) and Dickkopf-1 (DKK1) and the CC marker cytokeratin 7 (CK7), and a decreased expression of the CC tumour suppressor SRY-related HMG-box 17 (SOX17). Conclusion: We established HLF iPSCs using liver fibroblasts from a patient with cHCC-CC for the first time. The HLF iPSCs maintained marker expression in the patient when differentiated into EBs. Therefore, HLF iPSCs may be a sustainable cell source for modelling cHCC-CC and beneficial for understanding liver cancer pathology and developing therapies for cHCC-CC treatment.https://celljournal.org/journal/article/fulltext/generation-of-an-induced-pluripotent-stem-cell-line-from-human-liver-fibroblasts-of-a-patient-with-combined-hepatocellular-cholangiocarcinoma.pdfcholangiocarcinomahepatocellular carcinomainduced pluripotent stem cells
spellingShingle Hyo-Suk Ahn
Jae-Sung Ryu
Jaeseo Lee
Seon Ju Mun
Yeon-Hwa Hong
Yongbo Shin
Kyung-Sook Chung
Myung Jin Son
Generation of An Induced Pluripotent Stem Cell Line from Human Liver Fibroblasts from A Patient with Combined Hepatocellular-Cholangiocarcinoma
Cell Journal
cholangiocarcinoma
hepatocellular carcinoma
induced pluripotent stem cells
title Generation of An Induced Pluripotent Stem Cell Line from Human Liver Fibroblasts from A Patient with Combined Hepatocellular-Cholangiocarcinoma
title_full Generation of An Induced Pluripotent Stem Cell Line from Human Liver Fibroblasts from A Patient with Combined Hepatocellular-Cholangiocarcinoma
title_fullStr Generation of An Induced Pluripotent Stem Cell Line from Human Liver Fibroblasts from A Patient with Combined Hepatocellular-Cholangiocarcinoma
title_full_unstemmed Generation of An Induced Pluripotent Stem Cell Line from Human Liver Fibroblasts from A Patient with Combined Hepatocellular-Cholangiocarcinoma
title_short Generation of An Induced Pluripotent Stem Cell Line from Human Liver Fibroblasts from A Patient with Combined Hepatocellular-Cholangiocarcinoma
title_sort generation of an induced pluripotent stem cell line from human liver fibroblasts from a patient with combined hepatocellular cholangiocarcinoma
topic cholangiocarcinoma
hepatocellular carcinoma
induced pluripotent stem cells
url https://celljournal.org/journal/article/fulltext/generation-of-an-induced-pluripotent-stem-cell-line-from-human-liver-fibroblasts-of-a-patient-with-combined-hepatocellular-cholangiocarcinoma.pdf
work_keys_str_mv AT hyosukahn generationofaninducedpluripotentstemcelllinefromhumanliverfibroblastsfromapatientwithcombinedhepatocellularcholangiocarcinoma
AT jaesungryu generationofaninducedpluripotentstemcelllinefromhumanliverfibroblastsfromapatientwithcombinedhepatocellularcholangiocarcinoma
AT jaeseolee generationofaninducedpluripotentstemcelllinefromhumanliverfibroblastsfromapatientwithcombinedhepatocellularcholangiocarcinoma
AT seonjumun generationofaninducedpluripotentstemcelllinefromhumanliverfibroblastsfromapatientwithcombinedhepatocellularcholangiocarcinoma
AT yeonhwahong generationofaninducedpluripotentstemcelllinefromhumanliverfibroblastsfromapatientwithcombinedhepatocellularcholangiocarcinoma
AT yongboshin generationofaninducedpluripotentstemcelllinefromhumanliverfibroblastsfromapatientwithcombinedhepatocellularcholangiocarcinoma
AT kyungsookchung generationofaninducedpluripotentstemcelllinefromhumanliverfibroblastsfromapatientwithcombinedhepatocellularcholangiocarcinoma
AT myungjinson generationofaninducedpluripotentstemcelllinefromhumanliverfibroblastsfromapatientwithcombinedhepatocellularcholangiocarcinoma